Physician profile
Shan Jiang
NPI 1740774066
$1,512.93
in general payments reported to CMS, 2019-2025
26 companies · $503 in 2025
The $503 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $104 · 2023: $404 · 2024: $502 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,368 · Entertainment: $24.20 · Education: $16.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,368.17 |
| Entertainment | $24.20 |
| Education | $16.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $183.68 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $156.85 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $125.73 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $113.26 | 2023-2025 | |
| Hologic Sales and Service, LLC | $89.94 | 2024-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Shield Therapeutics INC | $88.06 | 2022-2025 | Accrufer |
| Exact Sciences Corporation | $77.62 | 2023-2025 | Cologuard Collection Kit |
| Millicent US INC | $75.69 | 2023-2025 | Femring, Intrarosa |
| Exeltis, USA INC. | $67.14 | 2022-2024 | Slynd |
| Abbvie INC. | $63.16 | 2023 | |
| Coopersurgical, INC. | $61.09 | 2024-2025 | Paragard T 380a |
| Organon LLC | $59.12 | 2022-2025 | Nexplanon |
| Smith+Nephew, INC. | $39.58 | 2025 | Pico 7 |
| Sumitomo Pharma America, INC. | $37.55 | 2023 | Myfembree |
| Pfizer INC. | $34.34 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $30.49 | 2025 | Perclot |
| Meditrina | $25.37 | 2024 | |
| Argentum Medical | $24.20 | 2024 | |
| Medtronic, INC. | $23.98 | 2024 | Truclear |
| Davol INC. | $22.44 | 2024 | Arista Ah Flexitip |
| Evofem Biosciences, INC. | $22.26 | 2024 | |
| Gynesonics, INC. | $20.10 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $19.82 | 2022 | |
| Ethicon US, LLC | $19.31 | 2025 | Enseal |
| Dilon Technologies, INC. | $16.93 | 2025 | Hemoblast Bellows |
| Dexcom, INC. | $15.22 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shan Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.